Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

NCT04065074 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Hip

Interventions

DRUG: FX006 32 mg

Sponsor

Pacira Pharmaceuticals, Inc